
Agetech World explores the latest investment developments in healthy ageing and longevity. US$10m to develop cell reset therapeutics for longevity Biotech company Junevity has raised US$10m...

Multinational pharmaceutical company AstraZeneca has teamed up with ‘young’ Chinese biotech Cholesgen to develop new drugs to target high cholesterol and related metabolic diseases. The three-year...